Key result
The provided text contains only the editorial board information for the journal Thrombosis and Haemostasis and lacks the actual study content.
Why the study?
Does single-dose oral rivaroxaban have predictable safety, pharmacokinetics, and pharmacodynamics in healthy elderly Chinese subjects?
Population
79 healthy, elderly Chinese subjects, aged 59-74 years (mean 62.8)
Comparison
Single once-daily oral doses of rivaroxaban 5… vs Placebo
Design
RCT, randomised, single-blind
Authors
Loading...
Supports standard rivaroxaban dosing in elderly Chinese patients; extends pharmacokinetic data to this population.
Does single-dose oral rivaroxaban have predictable safety, pharmacokinetics, and pharmacodynamics in healthy elderly Chinese subjects?
Single-dose oral rivaroxaban is well tolerated and exhibits predictable, dose-dependent pharmacokinetics and pharmacodynamics in healthy elderly Chinese subjects.
Jiang et al. (2009) studied this question. rivaroxaban was evaluated. The provided text contains only the editorial board information for the journal Thrombosis and Haemostasis and lacks the actual study content.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: